Qiagen N.V. (QGEN) Presents at Jefferies London Healthcare Conference 2025 Transcript

Group 1 - The company reported a core growth rate of 6% in the third quarter, which exceeded expectations [1] - The growth rates for the first three quarters of the year were 7% in Q1, 6% in Q2, and 6% in Q3, despite a challenging macro environment [2] - The company has been focusing on five growth drivers, which have been performing well [3] Group 2 - The company is facing challenges in various regions, including China and recent shutdowns in the U.S. [2] - The focus on specific growth areas has been beneficial for the company's performance [3]